Tag: biopharma
Shire launches “Rare Count” campaign to personalize global impact of rare...
For every “count,” Shire will donate to leading rare disease organizations. The campaign aims to reach out to 70 million patients in India who are living with a rare disease...
Science funding increases by 10%, bioscience gets 22% hike in budget...
The government's move to increase the funds for research and development in budget 2017, is expected to boost the innovation ecosystem in the country.....
760 jan ashudi stores functioning across India: Ananth Kumar
As per the union minister, currently over 450 medicines and 150 health supplements are available at around one-third the price of branded drugs at these stores....
Panacea launches tetravalent vaccine Easyfour-TT
Shares of Panacea Biotec surged more than 10 percent intraday Monday as the company launched world's first fully liquid tetravalent vaccine Easyfour-TT in India to protect children from vaccine-preventable diseases.....
US-FDA accepts Mylan & Biocon’s joint application on biosimilar Trastuzumab
While the Biologics License Application (BLA) for MYL-1401O has been accepted by the United States FDA, if approved, it has the potential to be the first biosimilar Trastuzumab in the US....
BioAsia 2017 to bring together top global pharma powerhouses to Hyderabad
World's top global pharma firms, Johnson & Johnson and Novartis along with GSK have confirmed their participation to be part of South Asia's largest technology and bio-business convention....
Panacea Biotec increases availability of life saving drug Cilamin 250
The New Delhi based biotech firm, Panacea Biotec has said that it has increased the supply of the life saving drug, Cilamin250 that had witnessed shortage in the market...
Strides Shasun grows 33% in 2nd quarter of FY 17
Revenues of the company stand at INR 4,366 Mn in Q2 FY17, representing 46 percent of total revenues.....
“Biotechnology in India needs a separate ministry”
Continuing our efforts to engage with the major political parties, we met Dr Ajoy Kumar, National Spokesperson, Indian National Congress...
Biotech companies join the ‘Make in India’ bandwagon
The promising biotechnology sector has joined the India centric manufacturing campaign in their own way if one goes....